Showing results (81-90 of 160) with videos related to
Sort By:
Pageof 16
Cancer Research|November 10, 2017
IDO Immune Status after Chemoradiation May Predict Survival in Lung Cancer PatientsWeili Wang, Lei Huang, Jian-Yue Jin, et al.Frontiers in Oncology|July 26, 2021
Genetic Variations in the Transforming Growth Factor-β1 Pathway May Improve Predictive Power for Overall Survival in Non-small Cell Lung CancerHong Zhang, Weili Wang, Wenhu Pi, et al.International Journal of Radiation Oncology, Biology, Physics|September 1, 2012
Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapyMatthew H Stenmark, Xu-Wei Cai, Kerby Shedden, et al.International Journal of Radiation Oncology, Biology, Physics|July 28, 2012
Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicityJingbo Wang, Jianzhong Cao, Shuanghu Yuan, et al.Oncotarget|December 13, 2017
Thoracic radiation-induced pleural effusion and risk factors in patients with lung cancerJing Zhao, Regina M Day, Jian-Yue Jin, et al.Journal of the National Cancer Center|July 22, 2024
Significance of radiation esophagitis: Conditional survival assessment in patients with non-small cell lung cancerHao Yu, Ka-On Lam, Michael D Green, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 26, 2018
Comparison of predictive powers of functional and anatomic dosimetric parameters for radiation-induced lung toxicity in locally advanced non-small cell lung cancerLinlin Xiao, Guoren Yang, Jinhu Chen, et al.Cancer Reports (Hoboken, N.J.)|August 14, 2021
Chemotherapy is a risk factor of lymphopenia before adjuvant radiotherapy in breast cancerFang Chen, Lingyu Ma, Qian Wang, et al.Nano Letters|March 12, 2010
Uptake and distribution of ultrasmall anatase TiO2 Alizarin red S nanoconjugates in Arabidopsis thalianaJasmina Kurepa, Tatjana Paunesku, Stefan Vogt, et al.Frontiers in Immunology|September 8, 2025
A phase II randomized trial of individualized neoantigen peptide vaccine combined with unusual radiotherapy (iNATURE) in advanced solid tumors-GCOG0028Yan Zhang, Ye-Fan Hu, Lingyu Ma, et al.Pageof 16